These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 15911089

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
    El-Khoury V, Breuzard G, Fourré N, Dufer J.
    Br J Cancer; 2007 Aug 20; 97(4):562-73. PubMed ID: 17667922
    [Abstract] [Full Text] [Related]

  • 7. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T.
    Mol Carcinog; 2005 Dec 20; 44(4):233-41. PubMed ID: 16163707
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors.
    Kikuchi T, Toyota M, Itoh F, Suzuki H, Obata T, Yamamoto H, Kakiuchi H, Kusano M, Issa JP, Tokino T, Imai K.
    Oncogene; 2002 Apr 18; 21(17):2741-9. PubMed ID: 11965547
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87.
    Grassi G, Maccaroni P, Meyer R, Kaiser H, D'Ambrosio E, Pascale E, Grassi M, Kuhn A, Di Nardo P, Kandolf R, Küpper JH.
    Carcinogenesis; 2003 Oct 18; 24(10):1625-35. PubMed ID: 12869421
    [Abstract] [Full Text] [Related]

  • 16. H3K9 acetylation and radial chromatin positioning.
    Strasák L, Bártová E, Harnicarová A, Galiová G, Krejcí J, Kozubek S.
    J Cell Physiol; 2009 Jul 18; 220(1):91-101. PubMed ID: 19248079
    [Abstract] [Full Text] [Related]

  • 17. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells.
    Hantusch B, Kalt R, Krieger S, Puri C, Kerjaschki D.
    BMC Mol Biol; 2007 Mar 07; 8():20. PubMed ID: 17343736
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibitors decrease reelin promoter methylation in vitro.
    Mitchell CP, Chen Y, Kundakovic M, Costa E, Grayson DR.
    J Neurochem; 2005 Apr 07; 93(2):483-92. PubMed ID: 15816871
    [Abstract] [Full Text] [Related]

  • 20. Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation.
    Gastaldi T, Bonvini P, Sartori F, Marrone A, Iolascon A, Rosolen A.
    Carcinogenesis; 2006 Sep 07; 27(9):1758-67. PubMed ID: 16537559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.